These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 33019241)

  • 1. Preliminary support for using the Atypicality Scale from the Behavior Assessment System for Children, Second Edition, to screen for psychosis-spectrum disorders within a college counselling centre.
    Thompson EC; DeLuca JS; Petti E; Rakhshan Rouhakhtar P; Schiffman J
    Early Interv Psychiatry; 2021 Apr; 15(2):406-411. PubMed ID: 32436366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent Factors of Language Disturbance and Relationships to Quantitative Speech Features.
    Tang SX; Hänsel K; Cong Y; Nikzad AH; Mehta A; Cho S; Berretta S; Behbehani L; Pradhan S; John M; Liberman MY
    Schizophr Bull; 2023 Mar; 49(Suppl_2):S93-S103. PubMed ID: 36946530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Language Abnormalities and Associated Clinical Markers in Psychosis: The Promise of Computational Methods.
    Hitczenko K; Mittal VA; Goldrick M
    Schizophr Bull; 2021 Mar; 47(2):344-362. PubMed ID: 33205155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of prosody to machine classification of schizophrenia.
    Ben Moshe T; Ziv I; Dershowitz N; Bar K
    Schizophrenia (Heidelb); 2024 May; 10(1):53. PubMed ID: 38762536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a scalable approach to assess speech organization across the psychosis-spectrum -online assessment in conjunction with automated transcription and extraction of speech measures.
    Olah J; Cummins N; Arribas M; Gibbs-Dean T; Molina E; Sethi D; Kempton MJ; Morgan S; Spencer T; Diederen K
    Transl Psychiatry; 2024 Mar; 14(1):156. PubMed ID: 38509087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated analysis of speech as a marker of sub-clinical psychotic experiences.
    Olah J; Spencer T; Cummins N; Diederen K
    Front Psychiatry; 2023; 14():1265880. PubMed ID: 38361830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toolkit to Examine Lifelike Language (TELL): An app to capture speech and language markers of neurodegeneration.
    García AM; Johann F; Echegoyen R; Calcaterra C; Riera P; Belloli L; Carrillo F
    Behav Res Methods; 2024 Apr; 56(4):2886-2900. PubMed ID: 37759106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Narrative Review of Speech and EEG Features for Schizophrenia Detection: Progress and Challenges.
    Teixeira FL; Costa MRE; Abreu JP; Cabral M; Soares SP; Teixeira JP
    Bioengineering (Basel); 2023 Apr; 10(4):. PubMed ID: 37106680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating temporal and prosodic markers in clinical high-risk for psychosis participants using automated acoustic analysis.
    Bianciardi B; Gajwani R; Gross J; Gumley AI; Lawrie SM; Moelling M; Schwannauer M; Schultze-Lutter F; Fracasso A; Uhlhaas PJ
    Early Interv Psychiatry; 2023 Mar; 17(3):327-330. PubMed ID: 36205386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facial and Vocal Markers of Schizophrenia Measured Using Remote Smartphone Assessments: Observational Study.
    Abbas A; Hansen BJ; Koesmahargyo V; Yadav V; Rosenfield PJ; Patil O; Dockendorf MF; Moyer M; Shipley LA; Perez-Rodriguez MM; Galatzer-Levy IR
    JMIR Form Res; 2022 Jan; 6(1):e26276. PubMed ID: 35060906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SPEAK study rationale and design: A linguistic corpus-based approach to understanding thought disorder.
    Bayer JMM; Spark J; Krcmar M; Formica M; Gwyther K; Srivastava A; Selloni A; Cotter M; Hartmann J; Polari A; Bilgrami ZR; Sarac C; Lu A; Yung AR; McGowan A; McGorry P; Shah JL; Cecchi GA; Mizrahi R; Nelson B; Corcoran CM
    Schizophr Res; 2023 Sep; 259():80-87. PubMed ID: 36732110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescents and young adults at ultrahigh risk of psychosis: detection, prediction and treatment. A review of current knowledge.
    Mees L; Zdanowicz N; Reynaert C; Jacques D
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S118-22. PubMed ID: 21894117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of at-risk symptoms for psychosis in children and adolescents.
    Schimmelmann BG; Walger P; Schultze-Lutter F
    Can J Psychiatry; 2013 Jan; 58(1):32-40. PubMed ID: 23327754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing acoustic and prosodic fluctuations in free speech to predict psychosis onset in high-risk youths.
    Agurto C; Pietrowicz M; Norel R; Eyigoz EK; Stanislawski E; Cecchi G; Corcoran C
    Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():5575-5579. PubMed ID: 33019241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of psychosis across protocols and risk cohorts using automated language analysis.
    Corcoran CM; Carrillo F; Fernández-Slezak D; Bedi G; Klim C; Javitt DC; Bearden CE; Cecchi GA
    World Psychiatry; 2018 Feb; 17(1):67-75. PubMed ID: 29352548
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.